Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.18 USD | +0.88% | +2.34% | +0.55% |
03-07 | Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024 | |
03-07 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2024 * | 43.3M 59.19M | Sales 2025 * | 165M 225M | Capitalization | 537M 734M |
---|---|---|---|---|---|
Net income 2024 * | -261M -357M | Net income 2025 * | -220M -301M | EV / Sales 2024 * | 7.91 x |
Net cash position 2024 * | 195M 266M | Net cash position 2025 * | 89.8M 123M | EV / Sales 2025 * | 2.71 x |
P/E ratio 2024 * |
-2.1
x | P/E ratio 2025 * |
-2.76
x | Employees | 452 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.33% |
Latest transcript on Phathom Pharmaceuticals, Inc.
1 day | +0.88% | ||
1 week | +2.34% | ||
Current month | -13.56% | ||
1 month | -16.92% | ||
3 months | +32.28% | ||
6 months | +6.00% | ||
Current year | +0.55% |
Managers | Title | Age | Since |
---|---|---|---|
Azmi Nabulsi
FOU | Founder | 64 | 18-01-08 |
Terrie Curran
CEO | Chief Executive Officer | 55 | 19-07-31 |
David Socks
FOU | Founder | 49 | 18-01-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Fields
BRD | Director/Board Member | 69 | 19-09-26 |
Frank Karbe
BRD | Director/Board Member | 56 | 22-04-24 |
Michael Cola
CHM | Chairman | 64 | 19-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.18 | +0.88% | 370,890 |
24-04-25 | 9.1 | -0.22% | 544,924 |
24-04-24 | 9.12 | +0.66% | 440,258 |
24-04-23 | 9.06 | +0.55% | 582,138 |
24-04-22 | 9.01 | +0.45% | 475,105 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.55% | 537M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PHAT Stock